Clinical Trial Update: Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating 123-I Iodobenzovesamicol (IBVM) with SPECT imaging in healthy subjects and patients with Alzheimer's disease and Parkinson's disease ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease

Drugs mentioned

• Iodobenzovesamicol (IBVM) (Iodobenzovesamicol)

Snippet

Sponsor: Institute for Neurodegenerative Disorders | Conditions: Alzheimer Disease, Parkinson Disease | Phase 2 | Status: COMPLETED